Nosopharm, a company dedicated to the research and development of new anti-infective drugs, today announces the appointment of
Marie-Paule Richard and Gilles Alberici to its supervisory board. Alberici will be its new chairman. These new appointees will strengthen Nosopharm’s board with their expert knowledge of the pharmaceutical industry and skills in the development of new antiinfective
therapies. They join Nosopharm’s existing supervisory board members: Gwenaël Hamon (Kreaxi, investment manager), Franck Lescure (Auriga Partners, partner) and Bernard Rivière (historic shareholder).

Complete press release : Nosopharm